Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
October 15, 2009 16:05 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced that it has resubmitted its filing to the U.S. Food & Drug Administration (FDA) for its...
Gregg Lapointe Appointed to Questcor Board of Directors
October 12, 2009 06:30 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., Oct. 12, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. announced today that Gregg A. Lapointe has been appointed to its Board of Directors. Mr. Lapointe, 50, is currently...
Questcor to Present At the 2009 Maxim Group Growth Conference in New York
September 25, 2009 10:00 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., Sept. 25, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the Maxim Group Growth Conference on Tuesday, September 29,...
Questcor Provides Update on Corporate Developments and Third Quarter Sales Trends
September 21, 2009 06:00 ET
|
Questcor Pharmaceuticals
Company Notifies FDA of Intention to Submit its sNDA for Acthar
for the Treatment of Infantile Spasms in October
Modest Sequential Growth Expected for Third Quarter Acthar...
Questcor to Present At the 2009 UBS Global Life Sciences Conference in New York
September 18, 2009 14:08 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., Sept. 18, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the UBS Global Life Sciences Conference on Tuesday,...
Questcor Pharmaceuticals to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
August 03, 2009 06:00 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that Don M. Bailey, President and Chief Executive Officer, will present at the BMO...
Questcor Reports Second Quarter 2009 Results
July 29, 2009 16:05 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., July 29, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its second quarter ended June 30, 2009. Net sales totaled $25.3...
Questcor Announces Second Quarter 2009 Earnings Release Date and Conference Call
July 20, 2009 06:30 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., July 20, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the second quarter ended June 30, 2009 on...
Questcor Launches New Corporate Website
July 09, 2009 08:09 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., July 9, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced it has launched a new corporate website with an easier to navigate format and content that...
Questcor Board Increases Share Repurchase Program Authorization
June 02, 2009 06:30 ET
|
Questcor Pharmaceuticals
UNION CITY, Calif., June 2, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that its Board of Directors has increased the Company's common share repurchase...